62. Multiplicity of Infection (MOI)

1. Introduction

Multiplicity of infection (MOI) is a fundamental concept in virology that describes the ratio of infectious viral units added to a population of target cells during an infection experiment.

It is widely used in viral propagation, cell culture experiments, virus titration, pathogenesis studies, antiviral drug testing, vaccine research and viral-vector production.

MOI helps investigators standardise experimental conditions and estimate how many infectious units are available per target cell. However, it is important to understand that MOI is an average ratio, not a guarantee that every cell receives the same number of infectious particles.

2. Definition

Multiplicity of infection (MOI) is the ratio of the number of infectious viral units added to a culture to the number of target cells exposed to those units.

[\boxed{\mathrm{MOI}=\frac{\text{Number of infectious viral units}}{\text{Number of target cells}}}]

MOI is conventionally expressed as a dimensionless ratio.

For example, if (10^6) infectious units are added to (10^6) cells, the nominal MOI is 1.

This does not mean that every cell receives exactly one infectious unit. Some cells may receive none, some one, and others multiple units.

3. Understanding MOI with a simple example

Suppose a laboratory culture contains 100,000 susceptible cells.

An investigator adds 100,000 infectious viral units.

[\mathrm{MOI}=\frac{100,000}{100,000}=1]

The nominal MOI is therefore 1.

Now consider three different conditions:

At MOI 0.1, there are 0.1 infectious units per cell on average. This does not mean that 10% of cells will necessarily become infected under every experimental condition.

The actual fraction infected depends on the distribution of infectious events, viral attachment and entry efficiency, cell susceptibility, the accuracy of the titre measurement and other experimental factors.

4. MOI is an average, not an individual-cell measurement

One of the most important concepts in MOI is that it describes the average infectious input across a cell population.

For example, an MOI of 5 means that five infectious units were added per target cell on average.

It does not mean that every cell receives five infectious units.

Some cells may receive no infectious units, while others may receive several.

If infectious units are distributed independently and randomly, the number of infectious units received by a cell can be approximated using a Poisson distribution.

This model is useful for estimating infection probabilities, although actual biological systems may depart from its assumptions.

5. Poisson distribution and MOI

The Poisson distribution describes the probability of observing a given number of events when events occur independently at a constant average rate.

In a simplified infection model, the mean number of infectious units per cell is the MOI, denoted by (m).

The probability that a cell receives exactly (k) infectious units is:

[\boxed{P(k)=\frac{m^k e^{-m}}{k!}}]

Where:

• (P(k)) = probability that a cell receives exactly (k) infectious units.

• (m) = MOI.

• (k) = number of infectious units received by the cell.

• (e) = base of the natural logarithm.

• (k!) = factorial of (k).

5.1 Probability that a cell receives no infectious units

For (k=0):

[P(0)=\frac{m^0e^{-m}}{0!}]

Since (m^0=1) and (0!=1):

[\boxed{P(0)=e^{-m}}]

Therefore, under the Poisson model, the probability that a cell receives at least one infectious unit is:

[\boxed{P(\geq1)=1-e^{-m}}]

This is a theoretical estimate of the fraction of cells receiving one or more infectious units, assuming the model's conditions are met.

5.2 Example: MOI = 1

When (m=1):

[P(0)=e^{-1}\approx0.368]

Thus, approximately 36.8% of cells are expected to receive no infectious units under the idealised model.

The probability of receiving at least one is:

[P(\geq1)=1-e^{-1}]

[\boxed{P(\geq1)\approx0.632=63.2%}]

Therefore, an MOI of 1 does not imply that 100% of cells will receive an infectious unit.

5.3 Expected distribution at different MOIs

<Chart content={{"chartType":"line","meta":{"title":"Theoretical fraction of cells receiving at least one infectious unit","description":"Poisson model: P(≥1) = 1 − e^(−MOI). These are theoretical probabilities, not guaranteed infection rates."},"xKey":"moi","series":[{"dataKey":"fraction","label":"Cells receiving ≥1 unit","valueFormat":"raw","valueSuffix":"%"}],"yAxisMin":0,"yAxisMax":100,"data":[{"moi":"0.1","fraction":9.5},{"moi":"0.5","fraction":39.3},{"moi":"1","fraction":63.2},{"moi":"2","fraction":86.5},{"moi":"3","fraction":95.0},{"moi":"5","fraction":99.3},{"moi":"10","fraction":100.0}]}}/>

The values are rounded. At MOI 10, the theoretical fraction is approximately 99.995%, rather than exactly 100%.

Clinical microbiology takeaway: MOI predicts the distribution of infectious input under specified assumptions. It does not directly measure the proportion of cells that will develop productive infection.

6. Calculation of MOI in laboratory practice

MOI can be calculated when the infectious titre of a viral preparation, the volume added and the number of target cells are known.

Formula

[\boxed{\mathrm{MOI}=\frac{\text{Viral titre}\times\text{Volume added}}{\text{Number of target cells}}}]

The viral titre must be expressed in infectious units per unit volume, and the volume must use compatible units.

Example 1: Calculating MOI

Suppose:

• Viral titre = (2\times10^7) PFU/mL

• Volume added = 0.5 mL

• Number of target cells = (1\times10^6)

First, calculate the total infectious units:

[2\times10^7\times0.5=1\times10^7\ \mathrm{PFU}]

Then calculate MOI:

[\mathrm{MOI}=\frac{1\times10^7}{1\times10^6}]

[\boxed{\mathrm{MOI}=10}]

The nominal MOI is 10 PFU per target cell.

Example 2: Calculating the required viral input

Suppose the intended MOI is 0.5, the culture contains (2\times10^6) cells, and the viral preparation has a titre of (4\times10^7) PFU/mL.

First, calculate the required infectious units:

[\text{Required units}=\mathrm{MOI}\times\text{Cell number}]

[=0.5\times2\times10^6]

[=1\times10^6\ \mathrm{PFU}]

Then calculate the corresponding volume:

[\text{Volume}=\frac{\text{Required infectious units}}{\text{Viral titre}}]

[=\frac{1\times10^6}{4\times10^7}]

[\boxed{\text{Volume}=0.025\ \mathrm{mL}=25\ \mu\mathrm{L}}]

This is a mathematical example; actual experimental conditions require validated methods appropriate to the virus and cell system.

7. Infectious titre and its relationship to MOI

MOI depends on the number of infectious units, not simply the total number of physical virus particles.

Common measures of infectious titre include:

• PFU/mL: Plaque-forming units per millilitre.

• TCID(_{50})/mL: Median tissue culture infectious dose per millilitre.

• IU/mL: Infectious units per millilitre, as defined by a particular assay.

These measures are not automatically interchangeable.

For example, PFU measures plaque-forming activity under the specified assay conditions. TCID(_{50}) is an endpoint-dilution measure of infectivity and is not numerically identical to PFU without an appropriate model or calibration.

The physical particle count may be substantially greater than the infectious titre because many particles are non-infectious under the assay conditions.

Therefore, using total particle numbers instead of infectious units can produce a different ratio.

8. MOI versus particle-to-infectivity ratio

The particle-to-infectivity ratio describes the number of physical particles relative to the number of infectious units.

MOI, by contrast, describes the number of infectious units added per target cell.

For example, a preparation may contain a large number of physical particles but relatively few infectious units.

Two preparations with the same physical particle count may therefore produce different nominal MOIs if their infectious titres differ.

The distinction is important in vaccine research, viral-vector quality control and studies of defective or inactivated particles.

9. Low MOI versus high MOI

The effects of MOI depend on the virus, cell type and experimental objective.

These are general tendencies, not universal rules.

A high nominal MOI does not guarantee synchronous infection, and a low MOI does not prevent some cells from receiving multiple infectious units.

10. MOI and single-cycle versus multicycle infection

MOI is particularly important when interpreting viral growth experiments.

Single-cycle infection studies

Investigators may use conditions intended to allow the initial infection event to be studied while minimising the contribution of later rounds of spread.

Such studies can examine early viral replication, gene expression, entry or cellular responses.

Multicycle infection studies

In multicycle experiments, newly produced viruses infect additional cells over time.

The number of infected cells can increase across successive rounds, even when the initial MOI is low.

Consequently, the initial MOI does not describe the effective infectious input throughout the entire experiment.

The distinction between the initial inoculum and subsequent viral spread is essential when interpreting growth curves and antiviral activity.

11. Factors affecting the relationship between MOI and infection

The Poisson model assumes that infectious units are distributed independently and randomly. Real experiments may violate these assumptions.

Important factors include:

11.1 Cell susceptibility

Not all cells are equally susceptible. Receptor expression, cell-cycle state, differentiation and intracellular antiviral responses can influence infection.

11.2 Viral attachment and entry

Some infectious units added to a culture may fail to attach or enter a cell.

11.3 Aggregation of viral particles

If particles aggregate, they may behave as a single infectious unit in an assay or may be delivered to cells non-randomly.

11.4 Accuracy of the viral titre

Errors in titre determination directly affect the calculated MOI.

11.5 Cell counting

An inaccurate target-cell count changes the calculated ratio.

11.6 Virus-to-cell compatibility

An infectious titre measured in one cell type may not predict infectivity in another cell type.

11.7 Defective interfering particles

Defective viral particles may be present in a preparation but may not be counted as infectious units by the assay used. They can nevertheless influence viral replication or cellular responses.

For these reasons, the nominal MOI and the biologically effective infection rate should be distinguished.

12. Applications of MOI in virology

12.1 Viral growth kinetics

MOI helps standardise the initial viral input when measuring viral replication over time.

12.2 Antiviral drug studies

MOI is an important experimental variable in antiviral assays because it can influence the extent of infection, the timing of viral spread and the interpretation of inhibitory effects.

12.3 Viral-vector research

In gene-delivery experiments, researchers may use a related concept called multiplicity of transduction, especially when discussing the number of vector infectious units applied per target cell.

The exact terminology and assay units depend on the vector platform.

12.4 Vaccine research

MOI may be used in studies involving viral vaccine strains, viral-vector vaccines and virus–cell interactions during production.

12.5 Viral genetics

MOI can influence the probability that two different viruses or viral variants infect the same cell, thereby affecting opportunities for complementation, phenotypic mixing and other coinfection-dependent phenomena.

However, the occurrence of any particular interaction also depends on viral compatibility and intracellular conditions.

12.6 Cytopathic effect studies

MOI can influence the timing and extent of cytopathic changes in susceptible cell cultures, although the relationship is virus- and cell-dependent.

13. Common misconceptions

Misconception 1: MOI = 1 means every cell receives exactly one infectious particle.

Correction: MOI is an average ratio. Under a Poisson model, approximately 63.2% of cells receive at least one infectious unit at MOI 1.

Misconception 2: An MOI of 10 means ten virus particles enter every cell.

Correction: It means ten infectious units are added per target cell on average. Actual uptake varies between cells.

Misconception 3: MOI and viral titre are the same.

Correction: Viral titre measures infectious activity per unit volume, whereas MOI relates infectious input to the number of target cells.

Misconception 4: Physical particle count can always be used to calculate MOI.

Correction: MOI conventionally uses infectious units. Total physical particles may include non-infectious particles.

Misconception 5: The Poisson distribution predicts the exact infection rate in every culture.

Correction: It provides a theoretical estimate under specific assumptions. Cell susceptibility, particle aggregation and entry efficiency can cause deviations.

Misconception 6: A low initial MOI means only a small proportion of cells will ever become infected.

Correction: During multicycle infection, newly produced virus can spread to additional cells.

14. High-yield examination points

• MOI is the ratio of infectious viral units added to the number of target cells.

• MOI is a dimensionless ratio.

• MOI 1 means one infectious unit per cell on average, not exactly one per cell.

• Under a Poisson model, (P(0)=e^{-m}).

• The fraction expected to receive at least one infectious unit is (1-e^{-m}).

• At MOI 1, approximately 63.2% of cells receive at least one infectious unit under ideal assumptions.

• PFU/mL and TCID(_{50})/mL are different infectivity measures and cannot automatically be interconverted.

• Initial MOI does not remain a complete description of infectious input during multicycle replication.

• High MOI generally increases the likelihood of coinfection but does not guarantee it.

• Nominal MOI may differ from the effective infection rate in a particular cell system.

15. Take-home message

Multiplicity of infection is a fundamental quantitative tool for standardising viral input in cell-based experiments. It connects viral infectivity measurements with the number of target cells and helps researchers interpret infection probabilities, viral growth and coinfection-dependent phenomena.

Its most important limitation is that MOI is an average infectious input, not a direct measurement of how many cells become productively infected. Correct interpretation requires attention to viral titre, cell susceptibility, entry efficiency and the assumptions behind the Poisson model.

16. Standard references

1. Knipe DM, Howley PM, editors. Fields Virology. 7th ed. Wolters Kluwer.

2. Flint SJ, Racaniello VR, Rall GF, Skalka AM, Enquist LW. Principles of Virology. 5th ed. ASM Press.

3. Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology. Elsevier.

4. Kärber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch Exp Pathol Pharmakol. 1931;162:480–483.

5. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Hyg. 1938;27(3):493–497.

The Reed–Muench and Kärber methods are commonly associated with endpoint-dilution titre calculations; they are not themselves definitions of MOI.